Vol.
167,
No.
February
1, 1990
28,
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS Pages
1990
A MOLLUSCAN
NEUROPEPTIDE
RELATED
TO THE CRUSTACEAN
273-279
HORMONE,
RPCH
Yoshihiro Kuroki, Tomoko Kanda, Ichiro Kubota+, Yuko Fujisawa, Tetsuya Ikeda, Atsushi Miura, Yoshiharu Minamitakef, and Yojiro Muneoka" Physiological Sciences, +Suntory #Suntory Received
Laboratory, Faculty Hiroshima University, Bio-Pharma
Tech Center, Gunma 370-05,
Institute
January
for
of Integrated Arts and Hiroshima 730, Japan Chiyoda-machi, Japan
Biomedical
Research,
Ohra-gun,
Osaka
Japan
618,
22, 1990
A peptide that potentiates twitch contraction of the radula retractor muscle of the prosobranch mollusc Fusinus ferrugineus was isolated from the ganglia of the animal. Its primary structure is H-Ala-Pro-Gly-Trp-NH (APGWamide) closely related to the C-terminal tetrapeptide OZ the crustacean red-pigmentconcentrating hormone. APGWamide showed modulatory actions on contractions in various molluscan muscles. 01990 Academic Press, Inc.
A number AKH have have
been
strongly substance isolated of *To
of
been
neuropeptides isolated
found
in
from other
suggested
that
related
to
a RPCH-related
a prosobranch
mollusc,
whom correspondence
which
belong
arthropods,
phyla'.
but
However,
molluscan RPCH-AKH2. bioactive
ganglia In
the
tetrapeptide
Fusinus should
to
ferrugineus.
the none
family
of
of
such
Greenberg
et
possess
RPCH-
peptides al.
have
a peptidic
present
study,
from
the
We report
we
ganglia here
be addressed.
Abbreviations: ABRM, anterior byssus retractor muscle; ACh, adipokinetic hormone; APGWamide, H-Ala acetylcholine; AKH, locust seawater; FAB-MS, fast atom -Pro-Gly-Trp-NH2; ASW, artificial N-(2-hydroxyethyl)bombardment mass spectrometry; Hepes, HPLC, high performance piperazine-N'-(2-ethanesulfonic acid); liquid chromatography; 5-HT, serotonin; PTH, phenylthiohydantoin; TFA, red-pigment-concentrating hormone; RPCH, crustacean tris(hydroxymethyl)aminomethane. trifluoroacetic acid; Tris, 0006-291X/90 $1.50 273
Copyright 0 1990 by Academic Press, Inc. All rights of reproduction in an.v form reserved.
Vol.
the
167,
No.
1, 1990
BIOCHEMICAL
purification,
activities
of
AND
structure the
RPCH-related MATERIALS
BIOPHYSICAL
determination molluscan
RESEARCH
and
COMMUNICATIONS
biological
neuropeptide.
AND METHODS
Animals---The animals used in the experiments are as follows: Euhadra congenita Fusinus ferrugineus (Prosobranchia), (Pulmonata) and Mytilus edulis (Bivalvia). Euhadra were collected in the campus of Hiroshima University. Fusinus and Mytilus were collected from Hiroshima Bay. Purification---The cerebral, suboesophageal and buccal of Fusinus. The acetone extract ganglia were excised from 1,100 of the ganglia was forced through C-18 cartridges (Waters SepPak). The retained material was eluted with methanol and gelThese filtrated with a column of Sephadex G-15 (26x400 mm). procedures were the same as those described previously3. The fractions showed four peaks of activities on twitch contractions of the radula retractor of Fusinus. However, each of the peaks seemed to be eluted partially overlapping with one or two other peaks. Therefore, we divided the active fractions into two The RPCH-related fractions 21-40 and fractions 41-58. wows, peptide was obtained from the latter group. The fractions of the latter group were pooled, concentrated and subjected to HPLC (Jasco TRI ROTAR VI) separation with a C-18 reversed-phase column (Tosoh ODS-80TM). The column was eluted with a 60-min linear gradient of O-60% acetonitrile in 0.1% TFA at pH 2.2. Three peaks of activities were obtained, twitchpotentiating, The active contractile and twitch-inhibiting peak. substance in the potentiating peak was then applied to a cationexchange column (Tosoh SP-5PW) and eluted with a 50-min linear gradient of O-O.5 M NaCl in 10 mM phosphate buffer at pH 6.8 Final purification was performed by applying the (Fig. IA). active material again to the C-18 reversed-phase column and eluting with a 30-min linear gradient of 15-20s acetonitrile in 0.1% TFA at pH 2.2 (Fig. IB). After each purification step, the bioactivity of each fraction was examined on train of twitch contractions of the isolated Fusinus radula retractor mounted in a chamber (2 ml). The methods of dissection, stimulation and recording from the muscle were the same as those described previously3. -The potentiating activity of the purified substance on the twitch contractions is shown in Fig. IC. Structure determination---The purified active substance was subjected to amino acid sequence analysis by automated Edman degradation with a gas-phase sequencer (Applied Biosystems 477A) coupled with a PTH-amino acid analyzer (Applied Biosystems 12OA), amino acid analysis (Hitachi L-8500) and FAB-MS analysis (JEOL JMS HX-TOO), and thus the probable structure of the substance was determined to be a tetrapeptide amide, APGWamide. The peptide was then synthesized by a manual solid-phase method followed by HF cleavage and HPLC purification. Its behavior on HPLC and bioactivity on the radula retractor were compared with those of the native peptide. Biological actions---Biological actions of APGWamide were examined on the following molluscan muscles: the radula retractor and protractor of Fusinus, the crop and the pharyngeal retractor of Euhadra, and the ABRM and the pedal retractor of Mytilus. These muscles, except the crop, were isolated and mounted in the same chamber used in the bioassay experiments. The methods of stimulation of the muscles and recording of tension from them 274
Vol. 167, No. 1, 1990
BIOCHEMICAL
0
20
40
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
hin)
Time
Fig. 1 HPLC purification of twitch-potentiating substance from the ganglia of Fusinus and bioactivity of the purified substance. A: the second step of the purification with a cation-exchange column. B: The third (final) step of the purification with a C-18 reversed-phase column. In A and B, bioactive peaks were coincident with the absorbance peaks indicated by arrows. c: potentiating action of the purified substance on train of twitches of the radula retractor of Fusinus. The train contr,actions were evoked by applying repetitive electrical pulses of stimulation (15 V, 2 msec, 0.2 Hz, 5 pulses) at 10 min intervals. The purified substance (PS) was applied to the muscle 8 min prior to the stimulation and washed out soon after it.
were also the same as those used in the bioassay experiments. APGWamide was applied to the muscles by replacing the solution in the chamber with the solution containing the peptide. The crop was excised by cutting at its both ends. The surrounding tissues were removed. The preparation was suspended in a 2-ml aerated organ bath. APGWamide was applied to the muscle by injecting the stock solution into the bath. Salines---The physiological saline for Mytilus muscles was ASW -of the following composition: 445 mM NaCl, 10 mM KCl, 10 mM CaC12, 55 mM MgC12 and 10 mM Tris-HCl; pH 7.8. For the saline of the Fusinus muscles, low-Mg2+ ASW (20 mM MgC12 ASW) was used to obtainlarge twitch contractions. This saline was made by replacing a part of MgCl2 in the normal ASW with osmotically equivalent NaCl. The physiological saline for the muscles of the land snail Euhadra was of the following composition: 120 mM NaCl, 4mM KCl, 0.9 mM CaC12, 2.5 mM MgC12, 1.5 mM glucose and 10 mM Hepes-NasOH; pH 7.5. RESULTS
The amino
determined acid
substance
in
the
were
Quantitative
sequence
as
amino
composition
normalizing
From
results,
whose
these structure
is
DISCUSSION
and
detected
acid
follows: acid
amino
AND
sequence
analysis
Ala65.3-Pro60
analysis
substance
H-Ala-Pro-Gly-Trp-OH 215
Pro, is
(pmol) of
of
the
each
purified
. .,-G~Y~~ . 3-Trp33.5.
showed the
on Ala=l: the
amount
0.8;
following Gly,
assumed or
its
amino acid
1.0; to
Ala,
1.0.
be a peptide
C-terminal
amide
Vol.
167,
No.
BIOCHEMICAL
1, 1990
derivative.
A molecular
MS
of
spectrum
the
the
ion
AND
BIOPHYSICAL
peak of
substance
429.1
in
was
RESEARCH
COMMUNICATIONS
(M+H)+
m/z
agreement
in the
with
FAB-
an amide at
C-terminus. The
at
synthesized
the
phase
APGWamide
identical column showed
elution
(Fig.
the a single
concluded
that
the
the
Trp-NH2).
The the
the
in both
of
total
yield
of
amino
acid
analysis
reversed-
of
of
the
the
cases dose
and
retractor
for
Thus,
we
Fusinus
peptide
is
to
the
from
the
related
is
(pGlu-Leu-Asn-Phe-Ser-Pro-GlyAPGWamide
calculated 3.01
was
nmol
from
1,100
animals.
0.03r
A
N.
A
c
,: ,,
oLL_lL L 0
n’;..:.. 20
/:’
N 1.’ /4
,S
.-.-
Timn
40
of
2C).
(Fig. the
eluted
mixture
radula
which
RPCH
C-18
between
of
structure
were
A
Fusinus
(APGWamide),
tetrapeptide
of
peak
identical
primary
C-terminal
result
in
almost
H-Ala-Pro-Gly-Trp-NH2
to
The relationship
action were
peptide
column.
absorbance
2A and 2B).
peptides
native
applied
cation-exchange
twitch-potentiating both
the
when
positions and
peptides
and
(min)
Fig. 2 Comparison of chromatographic properties and bioactivity of native peptide with those of synthetic APGWamide. A: reversed-phase chromatograms of the native (N) and synthetic (S) peptides and their mixture (N+S). B: cation-exchange chromatograms of the native (N) and synthetic (S) peptides and their mixture (N+S f . C: potentiating activities of the native (NJ and synthetic (S) peptides on total tension of 5 train twitches of the radula retractor of Fusinus. Each total tension is indicated as a percentage of the control total tension. The procedures for application of the peptides and recording of train twitches were the same as in Fig. IC. The concentrations of the native peptide were calculated from the result of amino acid analysis. 276
Vol.
167,
No.
BIOCHEMICAL
1, 1990
IO-‘M
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
APGWo
Fig. 3 Effects of APGWamide on some molluscan muscles. A: potentiating effect on train twitches of the radula retractor of Fusinus. B: inhibitory effect on train twitches of the radula protractor of Fusinus. The procedures in A and B were the same as in Fig. 1C. C: Inhibitory effect on spontaneous contractions of the crop of Euhadra. At downward arrow, the crop was washed with normal saline for 10 min. D: inhibitory effect on tetanic contraction of the ABRM of Mytilus. Tetanic contraction was evoked by applying repetitive electrical pulses of stimulation (15 V,, 3 msec, 10 Hz, for 5 set) at 10 min intervals. The other procedures were the same as in Fig. 1C. E: inhibitory effect on relaxation of catch tention in response to repetitive electrical pUlSeS of stimulation (15 V, 2 msec, 1 Hz, 15 pulses) in the ABRM of w:ilus. Catch tension was produced by applying ACh for 2 min
at 20 minintervals.
Although
APGWamide
contractions
in
the
inhibitory
action
thresholds
for M and
~xIO-'~
twitches,
even
by
In
of
M,
of
muscles,
the
not
only
muscles
the
crop
retractor
contractions were
(Fig.
of Euhadra of the
also
ABRM (Fig.
inhibited
by
the
of
the
ABRM was not
tension
were
not
M or higher
10v7
of
the
development 277
twitch
3D) and the
ACh contraction
contraction
the
were inhibited
inhibition
by
to
3C) and
the
potentiated
inhibit
the
contrast
for
but
tetanic
were approximately In
of
The
3A and B).
thresholds
M.
In the
(Fig.
showed an
peptide. of
Mytilus
3x1O-1o-1O-g
slightly
the
both
on twitch it
Fusinus,
respectively.
pharyngeal
Tetanic
of
and inhibition
in
M of
10d5
action
protractor
potentiation
the
retractor
these
radula
contractions
by APGWamide. pedal
a potentiating
retractor
contractions
Spontaneous contraction
the
5~10~~
ACh
affected
radula
in
the
showed
peptide.
were between inhibited
APGWamide.
ABRM, APGWamide was found but
also
relaxation
to
(Fig.
Vol.
167,
No.
I,
1990
BIOCHEMICAL
Therefore,
3D).
relaxation stimuli.
catch
The in
stimulation
(Fig.
in
response
relaxing
relaxing
M.
It
has
applied
been
to
relaxing
ABRM relax
nerves
to
the
suggest
that
has
by
also
been
transmitter
in
potentiates
tetanic
peak
tension
result
of
tested
5-HT
twitch
contractions
whereas
closely potent In molluscan
of
tetanic
of
that
RPCH of
retractor
the
protractor
to
Fusinus
muscles,
.
In
decrease might
found
a We
that
the
amine,
muscles
Yanagawa
this
be
by the
radula
a
in
The actions
the
is
5-HT
release.
inhibited
contractions
which
relaxing
that
5-HT and
release.
relaxing
the
The
on
ABRM
elements.
shown
Fusinus
of
the
the
of
potentiated.
twitch
10
of
APGWamide
peptide
contractions
twitch-inhibiting summary,
in
were
thomasiana
5-HT6r7.
nerve
ABRM7!'.
of
5-HT
intramuscular
from
been
the
were
of
5-HT
release
has
the
of
potentiates
Rapana
related
of muscles
inhibition
of
the
pulses
experiments
contraction
radula
twitch
the
inhibit
contraction
of
approximately
the
intramuscular
It
the
on the
be results
retractor
of
to
action
the
the
ABRM8.
the
on
on
catch-
inhibition
transmitter
release
suggested
inhibitory
those
APGWamide
shown
of
in
and
was
of
relaxation
electrical
relaxing
the
pulses
5-HT,
stimulating
by
inhibits
the
the
repetitive
catch
acting
as
stimulation
that
on
on the
such
on
relaxing
effect
no effect
for
obtained
APGWamide
terminals
showed
release
results
various
electrical
threshold
suggested
APGWamide
inhibitory
electrical
the
Therefore,
nerve
The
to
repetitive
it
COMMUNICATIONS
of
response
monoamines4,
by repeititve
5x10-"
RPCH
but
RESEARCH
effect
potent
to
3E),
peptide5.
relaxation
in
showed
response
to
the
tension
peptide
relaxation
BIOPHYSICAL
examined
we
of
AND
et of
muscle,
might
al.
have
the
prosobranch 5-HT
of
radula mollusc
is
also
a
agent".
APGWamide further,
is
structurally both 278
of
related the
peptides
to seem
RPCH.
In
to
show
Vol.
167,
NON. 1, 1990
BIOCHEMICAL
qualitatively
similar
peptides of
5-HT
on
the
AND
BIOPHYSICAL
actions.
muscles
of
Some
may be
RESEARCH
brought
the
about
COMMUNICATIONS
actions through
of
the
inhibition
release. ACKNOWLEDGMENTS
The Y.
authors
wish
to
express
and
Dr.
T.
Shimonishi
spectroscopic
their Takao
sincere
thanks
(Osaka
to
University)
Professor for
mass
measurement. REFERENCES
1. 2. 3.
Penzlin, H. (1989) Naturwissenschaften 76, 243-252. Greenberg, M. J., Rao, K. R., Lehman, H. K., Price, D. A. and Doble, K. E. (1985) J. exp. Zool. 233, 337-346. Kanda, T., Takabatake, I., Fujisawa, Y., Ikeda, T., Muneoka, M. (1989) Hiroshima J. Med. Sci. 38, 106Y. and Kobayashi, 116.
4. 5.
Twarog, B. M. and Cole, R. 46A, 831-835. Hirata, T., Kubota, I., Shimamoto, N. and Muneoka,
A.
Comp.
(1973)
Takabatake, Y. (1987)
Biochem.
I., Brain
Physiol.
Kawahara, Res. 422,
A., 374-
376. 6. 7.
Cambridge, G. W., Holgate, J. A. Phylsiol. Lond. 148, 451-464. York, B. and Twarog, B. M. (1973)
and Sharp, Comp.
J.
A.
(1959)
J.
Biochem.Physiol.44A,
423-430. 8. 9.
Saitoh, 389-395. Muneoka, 73C,
10. 11.
149-l
Yanagawa, Kobayashi Muneoka, 65C,
H. and Muneoka, Y.
and
Kamura,
Y.
(1986)
M.
(1982)
Hiroshima Comp.
J.
Med.
Biochem.
Sci.
35,
Physiol.
56.
M., Fujiwara, M., Takabatake, I., Muneoka, Y. and M. (1988) Comp. Biochem. Physiol. 9OC, 73-77. Y. and Kobayashi, M. (1980) Comp. Biochem. Physiol.
81-86.
279